News from auspex pharmaceuticals

May 07, 2014, 08:00 ET

Auspex Pharmaceuticals Appoints Industry Veterans Lynn Bleil And Scott Greer To Its Board Of Directors

 Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and...

Mar 31, 2014, 16:57 ET

Auspex Pharmaceuticals Added To The Russell 2000® Index

Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel...

Mar 27, 2014, 16:19 ET

Auspex Pharmaceuticals Reports 2013 Fourth Quarter And Full Year 2013 Financial Results

 Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel...

Mar 25, 2014, 16:01 ET

Auspex Announces The Issuance Of Patents On Deuterium-Containing Form Of Pirfenidone (SD-560)

Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel...

Mar 24, 2014, 08:00 ET

Auspex To Present at BioCentury's Future Leaders in the Biotech Industry Conference

Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel...

Feb 10, 2014, 16:00 ET

Auspex Announces Completion Of Initial Public Offering And Exercise In Full Of Underwriters' Over-Allotment Option

Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a biopharmaceutical company focused on developing and commercializing novel medicines for the...

Feb 05, 2014, 00:07 ET

Auspex Announces Pricing Of Initial Public Offering

 Auspex Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of...

Jan 08, 2014, 08:00 ET

Auspex Raises $35 Million And Appoints Industry Veteran Gerald Proehl To Its Board of Directors

 Auspex Pharmaceuticals, Inc., a Phase 3 clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for...

Oct 17, 2013, 08:00 ET

Auspex Appoints Pratik Shah as CEO and Expands Executive Team

 Auspex Pharmaceuticals, Inc., a privately-held clinical stage biopharmaceutical company focused on developing innovative therapeutics for the...

Jul 11, 2013, 11:05 ET

Auspex Initiates Phase 3 Trial of SD-809 in Huntington's Disease

 Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead...

Nov 15, 2012, 08:30 ET

Auspex Pharmaceuticals Receives U.S. Patent on Novel JAK Inhibitor SD-900

Auspex Pharmaceuticals, Inc. today announced that it has been granted U.S. Patent No. 8,299,084 covering the company's novel JAK kinase inhibitor...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge